(A) Scheme of viral strategy for retrograde tracing from the PVN in Cck-cre mice using AAV2-Retro virus. (B) Representative image showing the injection site as marked by CTB555. (C) Representative …
Quantification of the labeled cells, EPSCs and IPSCs.
(A) Schematic of mice crossing to generate the Cck-ires-cre::Ai14 mice. (B) Representative coronal section images illustrating the expression of CCK-tdT in the LPB; scale bar, 100 μm. (C) …
Quantification of LPB CCK-tdT cells.
(A–I) Representative images showing the projections from LPBCCK neurons in the median preoptic nucleus (MnPO), lateral preoptic area (LPO), paraventricular thalamic nucleus (PVT), ventromedial …
(A) Left, schematic of light stimulation of and patch-clamp recording from ChR2-EYFP expressing CCK neurons in the LPB. Right, example of action potentials evoked by optogenetic stimulation LPBCCK …
Quantification of the flight-to-nest behavior and autonomic responses upon activation of LPB CCK neurons.
(A) Schematic of behavioral test protocol. OFT, open-field test; EPM, elevated plus maze test. (B) Experimental apparatus: Open field. (C) Example movement traces of a control (AAV2/9-EF1a-DIO-EYFP, …
Quantification of the anxiety-like behavior.
(A) Schematic of the in vivo recording system for the Ca2+ signal. (B) Schematic showing the injections and recording of LPB neurons in Cck-cre mice. (C) A representative image (left panel) and a …
Plot depicting the difference of Ca2+ activity.
(A) A schematic of the heat assay. (B) Representative trial-by-trial heatmap presentation of calcium transients evoked by heat exposure in five trials from one mouse. (C) Representative peri-event …
(A) Left, schematic of light stimulation of and patch-clamp recording of GtACR1-expressing CCK neurons in the LPB. Right, example of action potentials evoked by optogenetic inhibition of LPBCCK …
Quantification of the defensive responses upon inhibition of LPB CCK neurons.
(A) Schematic diagram of optogenetic activation of LPBCCK-PVN pathway. (B–C) A representative image showing the ChR2-EYFP expression in the LPB (B) and the optical fiber tip locations in the PVN (C) …
Quantification of the flight-to-nest behavior and autonomic responses upon activation of LPB CCK-PVN pathway.
The square boxes indicate the location of virus expression and circles represent optical fiber location (G-L).
(A) Schematic of experimental setup. (B) Left, representative image showing the ChR2-EYFP expression in the LPB of a Cck-cre mouse. Scale bar, 100 μm. Right, representative image showing the …
Quantification of the flight-to-nest behavior upon manipulation of PVN neurons.
Maps for virus expression and optical fiber location.
(A–B) Representative histological images showing Cckar and Cckbr in the PVN. (C) C-fos expression and colocalization (arrows) with CRH in the PVN with blue light activation of LPB-originating …
Quantification of the CRH neurons and flight-to-nest behavior.
ISH data from the Allen Brain Atlas showed that Vglut2 neurons are located in the PVN (A), whereas GABAergic neurons are almost excluded from the PVN region by surrounding the PVN (B).
The circles represent optical fiber location (G-I).
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | Cck-ires-cre(Ccktm1.1(cre)Zjh/J) | The Jackson Laboratory | JAX012706 | |
Strain, strain background (Mus musculus) | Crh-ires-cre (B6(Cg))-Crhtm1(cre)Zjh/J | The Jackson Laboratory | JAX012704 | |
Strain, strain background (Mus musculus) | Vglut2-ires-Cre (Slc17a6tm2(cre)Lowl/J) | The Jackson Laboratory | JAX 016963 | |
Strain, strain background (Mus musculus) | Ai14 (B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J) | The Jackson Laboratory | JAX007908 | |
Strain, strain background (Rattus norvegicus) | SD | Shanghai SLAC Laboratory Animal Co. Ltd | http://www.slaccas.com/ | |
Strain, strain background (Mus musculus) | C57BL/6 J | Shanghai SLAC Laboratory Animal Co. Ltd | http://www.slaccas.com/ | |
Antibody | Anti-Dsred, rabbit polyclonal | Takara | Cat# 632496 RRID: AB_10013483 | (1:800) |
Antibody | Anti-CGRP, mouse monoclonal | Abcam | Cat# 81887 RRID: AB_1658411 | (1:800) |
Antibody | Anti-GFP, goat polyclonal | Abcam | Cat# 5450 RRID: AB_304896 | (1:500) |
Antibody | Anti-CRH, rabbit polyclonal | Phoenix Biotech | Cat# H-019–06 | (1:500) |
Antibody | Anti-c-fos, Guinea pig polyclonal | Synaptic Systems | Cat# 226004 RRID: AB_2619946 | (1:10,000) |
Antibody | Alexa Fluor 488 donkey anti-guinea pig IgG (H+L) polyclonal | Jackson | Cat#112-486-068 RRID: AB_2617153 | (1:1000) |
Antibody | Alexa Fluor 555 donkey anti-rabbit IgG (H+L) polyclonal | Invitrogen | Cat#A31572 RRID: AB_162543 | (1:1000) |
Antibody | Alexa Fluor 488 donkey anti-mouse IgG (H+L) polyclonal | Invitrogen | Cat# R37114 RRID: AB_2556542 | (1:1000) |
Antibody | Alexa Fluor 488 donkey anti-goat IgG (H+L) polyclonal | Invitrogen | Cat# A11055 RRID: AB_2534102 | (1:1000) |
Antibody | Alexa Fluor 488 donkey anti-rabbit IgG (H+L) polyclonal | Jackson | Cat# R37118 RRID: AB_2556546 | (1:1000) |
Commercial assay or kit | RNAscope Multiplex Fluorescent Reagent Kit v2 | Advanced Cell Diagnostics | Cat# 323100 | |
Sequence-based reagent | RNAscope probe Slc17a6 | Advanced Cell Diagnostics | accession number NM_080853.3 | probe region 1986–2998 |
Sequence-based reagent | RNAscope probe Slc32a1 | Advanced Cell Diagnostics | Accession number NM_009508.2 | probe region 894–2037 |
Sequence-based reagent | RNAscope probe Cckar | Advanced Cell Diagnostics | accession number NM_009827.2 | probe region 328–1434 |
Sequence-based reagent | RNAscope probe Cckbr | Advanced Cell Diagnostics | accession number NM_007627.4 | probe region 136–1164 |
Chemical compound, drug | CNQX disodium salt hydrate | Sigma-Aldrich | Cat#1045 | |
Chemical compound, drug | Devazepide | Sigma-Aldrich | Cat#2304 | |
Chemical compound, drug | Clozapine N-oxide | Sigma-Aldrich | Cat#C0832 | |
Chemical compound, drug | L-365,260 | Sigma-Aldrich | Cat#143626 | |
Chemical compound, drug | DAPI | Sigma-Aldrich | N/A | |
Chemical compound, drug | Tween-20 | Sigma-Aldrich | N/A | |
Strain, strain background (AAV2/9) | AAV2/9-hEF1a-DIO-hChR2(H134R)-EYFP-WPRE-pA | Shanghai Taitool Bioscience Co. | Cat# S0199-9 | Viral titers: 2.95x1013 particles/ml |
Strain, strain background (AAV2/9) | AAV2/9-hEF1a-DIO-EYFP-WPRE-pA | Shanghai Taitool Bioscience Co. | Cat#S0196-9 | Viral titers:1.0x1012 particles/ml |
Strain, strain background (AAV2/9) | AAV2/9-CAG-DIO-hGtACR1-P2A-EGFP-WPRE-pA | Shanghai Taitool Bioscience Co. | Cat# S0311-9 | Viral titers:5×1013 particles/ml |
Strain, strain background (AAV2/9) | rAAV2/9-hSyn-DIO-mGFP-2A-Synaptophysin-mRuby | Shanghai Taitool Bioscience Co. | Cat# S0250-9 | Viral titers:1.55x1013 particles/ml |
Strain, strain background (AAV2/2) | rAAV2/2-Retro-hEF1a-DIO-EYFP-WPRE-pA | Shanghai Taitool Bioscience Co. | Cat# S0196-2R | Viral titers: 2.52x1013 particles/ml |
Strain, strain background (AAV2/9) | AAV2/9-hSyn-mCherry-WPRE-pA | Shanghai Taitool Bioscience Co. | Cat# S0238-9 | Viral titers:≥1.0 × 1013 particles/ml |
Strain, strain background (AAV2/9) | AAV2/9-hSyn-hM4D(Gi)-mCherry-WPRE-pA | Shanghai Taitool Bioscience Co. | Cat# S0279-9 | Viral titers:≥1.0 × 1013 particles/ml |
Strain, strain background (AAV2/9) | AAV2/9-hsyn-DIO-jGCaMP7s-WPRE-pA | Shanghai Taitool Bioscience Co. | Cat# S0590-9 | Viral titers:≥1.0 × 1013 particles/ml |
Software, algorithm | ANY-Maze software 5.3 | Global Biotech Inc | http://www.anymaze.co.uk/ | |
Software, algorithm | Image J | NIH | https://imagej.nih.gov/ij/index.html;%20 RRID:SCR_003070 | |
Software, algorithm | GraphPad Prism 6 | GraphPad Software | https://www.graphpad.com/scientificsoftware/prism/; RRID: SCR_002798 | |
Software, algorithm | MatLab R2016a | MathWorks | https://www.mathworks.com/products.html; RRID:SCR_001622 |
Animal 1 | ||||||
---|---|---|---|---|---|---|
Region | Slice 1 | Slice 2 | Slice 3 | total | percentage | average |
CC | 94 | 103 | 95 | 292 | 25.75% | 97 |
DI | 11 | 34 | 21 | 66 | 5.82% | 22 |
LPB | 71 | 103 | 69 | 243 | 21.43% | 81 |
PAG | 26 | 34 | 19 | 79 | 6.97% | 26 |
MO | 137 | 175 | 142 | 454 | 10.04% | 151 |
Animal 2 | ||||||
Region | Slice 1 | Slice 2 | Slice 3 | total | percentage | average |
CC | 82 | 93 | 75 | 250 | 21.82% | 83 |
DI | 18 | 23 | 17 | 58 | 5.06% | 19 |
LPB | 94 | 102 | 91 | 287 | 25.04% | 96 |
PAG | 11 | 23 | 15 | 49 | 4.28% | 16 |
MO | 166 | 172 | 164 | 502 | 43.80% | 167 |
Animal 3 | ||||||
Region | Slice 1 | Slice 2 | Slice 3 | Total | percentage | average |
CC | 80 | 95 | 76 | 251 | 24.25% | 84 |
DI | 27 | 32 | 28 | 87 | 8.41% | 29 |
LPB | 67 | 82 | 63 | 212 | 20.48% | 71 |
PAG | 12 | 19 | 16 | 47 | 4.54% | 16 |
MO | 139 | 157 | 142 | 438 | 42.32% | 146 |
Region | Total average | |||||
CC | 88 | |||||
DI | 23 | |||||
LPB | 83 | |||||
PAG | 19 | |||||
MO | 155 |
Animal | Stage | Hot zone : time | Safe zone : latency to first entry | Hot zone time/total time | Optical fiber location | |
---|---|---|---|---|---|---|
GtACR1 | 1 | Habitat stage | 96.5 | Optical fibers in only one side | ||
Test stage | 36.7 | 13.5 | 12.23% | |||
2 | Habitat stage | 60.8 | Optical fibers in only one side | |||
Test stage | 70 | 67.0 | 23.33% | |||
3 | Habitat stage | 13.4 | ||||
Test stage | 265.7 | 265.7 | 88.57% | |||
4 | Habitat stage | 151.2 | ||||
Test stage | 300 | 300.0 | 100.00% | |||
5 | Habitat stage | 176.7 | ||||
Test stage | 300 | 300.0 | 100.00% | |||
6 | Habitat stage | 70.6 | Optical fibers in only one side | |||
Test stage | 93 | 91.7 | 31.00% | |||
7 | Habitat stage | 33.7 | ||||
Test stage | 137.9 | 106.7 | 45.97% | |||
EYFP | 8 | Habitat stage | 84.8 | |||
Test stage | 72.9 | 2.3 | 24.30% | |||
9 | Habitat stage | 41.9 | ||||
Test stage | 18.4 | 5.6 | 6.13% | |||
10 | Habitat stage | 14.9 | ||||
Test stage | 6.7 | 2.4 | 2.23% | |||
11 | Habitat stage | 77.6 | ||||
Test stage | 44.9 | 9.0 | 14.97% | |||
12 | Habitat stage | 137.3 | ||||
Test stage | 52 | 7.5 | 17.33% | |||
13 | Habitat stage | 75.8 | ||||
Test stage | 41.3 | 38.0 | 13.77% | |||
14 | Habitat stage | 149.4 | ||||
Test stage | 108.9 | 108.9 | 36.30% | |||
15 | Habitat stage | 30.8 | ||||
Test stage | 6.8 | 4.1 | 2.27% |
Number of labeled cells | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
animal 1 | animal 2 | animal 3 | total average | ||||||||||||||||||
region | slice 1 | slice 2 | slice 3 | total | percentage | average | region | slice 1 | slice 2 | slice 3 | total | percentage | average | region | slice 1 | slice 2 | slice 3 | total | percentage | average | |
CC | 94 | 103 | 95 | 292 | 25.75% | 97 | CC | 82 | 93 | 75 | 250 | 21.82% | 83 | CC | 80 | 95 | 76 | 251 | 24.25% | 84 | 88 |
DI | 11 | 34 | 21 | 66 | 5.82% | 22 | DI | 18 | 23 | 17 | 58 | 5.06% | 19 | DI | 27 | 32 | 28 | 87 | 8.41% | 29 | 23 |
LPB | 71 | 103 | 69 | 243 | 21.43% | 81 | LPB | 94 | 102 | 91 | 287 | 25.04% | 96 | LPB | 67 | 82 | 63 | 212 | 20.48% | 71 | 83 |
PAG | 26 | 34 | 19 | 79 | 6.97% | 26 | PAG | 11 | 23 | 15 | 49 | 4.28% | 16 | PAG | 12 | 19 | 16 | 47 | 4.54% | 16 | 19 |
MO | 137 | 175 | 142 | 454 | 40.04% | 151 | MO | 166 | 172 | 164 | 502 | 43.80% | 167 | MO | 139 | 157 | 142 | 438 | 42.32% | 146 | 155 |